TAILIEUCHUNG - Three-dimensional thoraco laparoscopic surgery in treatment of esophageal cancer: Initial experience at Vietnam national cancer hospital

Objectives: To evaluate the early results of three dimensional thoraco-laparoscopic surgery in esophageal cancer. Subjects and methods: This is a retrospective, descriptive study. Patients with esophageal cancer and undergoing three-dimensional thoraco-laparoscopic esophagectomy and lymphadenectomy were recruited. Surgery and postoperative information including postoperative complications were reported. | Journal of military pharmaco-medicine no1-2019 THREE-DIMENSIONAL THORACO-LAPAROSCOPIC SURGERY IN TREATMENT OF ESOPHAGEAL CANCER: INITIAL EXPERIENCE AT VIETNAM NATIONAL CANCER HOSPITAL Pham Van Binh1,2; Nguyen Van Hung1,2 SUMMARY Objectives: To evaluate the early results of three dimensional thoraco-laparoscopic surgery in esophageal cancer. Subjects and methods: This is a retrospective, descriptive study. Patients with esophageal cancer and undergoing three-dimensional thoraco-laparoscopic esophagectomy and lymphadenectomy were recruited. Surgery and postoperative information including postoperative complications were reported. Results: 17 patients underwent completely three-dimensional endoscopic surgery. The mean age was 51 years old. The average duration of surgery was 260 minutes. The mean blood loss was 105 mL. The mean number of harvested lymph nodes was 12. Surgical margins were negative in all patients. The average hospital stay was 12 days. 1 patient had pneumonia. There was 1 patient with subcutaneous emphysema. Wound infection was reported in 1 patient. There was no case of anastomotic leakage as well as postoperative death within 30 days. Conclusion: Initially, three-dimensional thoraco-laparoscopic surgery in esophageal cancer shows safety, feasibility and promise. * Keywords: Esophageal cancer; Three-dimensional thoraco-laparoscopic surgery; Initial experience. INTRODUCTION The global prevalence of esophageal cancer has increased 50% during the past two decades. Each year, there is approximately 482,300 new cases of esophageal cancer and deaths due to this disease. The American Cancer Society estimates that in 2018, there are about 17,290 new cases and 15,850 deaths from esophageal cancer. Although esophageal cancer is still one of the poorest prognosis cancers, the efforts of oncological surgeons have improved significantly 5-year survival from 5% in 1960s to around 20% in the present [1, 2, 3]. Until now, esophageal cancer management has .

• Y khoa - Dược
• Esophageal cancer
• Three dimensional
• Thoraco laparoscopic surgery
• Initial experience
• Laparoscopic esophagectomy
• BMC Cancer
• Esophageal fistula
• Risk factor
• Multivariate logistic regression analysis
• Esophageal adenocarcinoma
• Esophageal squamous cell carcinoma
• Cox’s proportional hazards analysis
• Esophageal cancer surgery
• Surgical procedures performed
• Squamous cell carcinoma
• Tissue microarray
• RBM3 expression
• Cancer types
• Esophageal epithelium
• Neoadjuvant therapy
• Cyclooxygenase 2 inhibition
• Humans suggest
• Esophageal cancer risk
• Paclitaxel carboplatin
• Gastro esophageal junctional cancer
• Platinum analogue
• Angiogenic factors
• Despite multimodal therapy esophageal cancer
• Angiogenic cytokine
• Multiplex immunoassay
• Epidermal growth factor receptor
• Meta analysis
• Metastatic esophageal cancer
• Standard treatment
• Concurrent chemoradiotherapy
• 3D conformal radiation therapy
• Non surgical esophageal cancer
• 103 Military Hospital
• Upper third esophageal cancer
• Intensity modulated radiation therapy
• Intensitymodulated radiation
• Esophageal cancer patients
• Thoracoscopic esophagectomy
• Results of thoracoscopic esophagectomy
• 103 Military Hospital 103
• Palliative treatment
• Inoperable esophageal cancer
• Partially covered self expanding metallic stents
• Quality of life
• Comparative effectiveness
• Prior systematic
• 18FDG PET CT simulation
• 3D conformal radiotherapy
• CT simulation in 3D conformal
• Chemo radiotherapy for esophageal cancer
• Definitive chemoradiation
• Acute toxicity
• Irresectable esophageal cancer
• Esophageal neoplasms
• Response evaluation criteria in solid tumors
• Mental disorder
• Gastric cancer
• Cohort study
• Cancer treatment
• Waiting time
• Narrow band imaging
• Head and neck cancer
• Second primary cancer
• Whole exome sequencing
• Fastq2vcf modified
• Generation sequencing
• Lymph node metastases
• Esophageal carcinoma
• Invasion depth
• Neoadjuvant treatment
• Digestive system
• RAS oncogene family like 6
• Several cancers
• Prognostic factor
• Controlling nutritional status
• Tumor development
• PHLPP2 proteins
• Aurora A
• Chemoradiation therapy
• DNA repair